Wall Street Zen Upgrades Nu Skin Enterprises (NYSE:NUS) to "Strong-Buy"

Key Points

• Nu Skin Enterprises has been upgraded from a "buy" to a "strong-buy" rating by stock analysts at Wall Street Zen, signaling increased investor confidence in the stock.
• Currently, the stock has a consensus rating of "Hold" from various analysts, with a price target of $6.88, despite a recent trading down of 6.6%.
• Insider trading activity shows notable sales, with director Laura Nathanson selling 6,489 shares, indicating potential caution among company executives regarding stock performance.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a note issued to investors on Sunday.

Other equities research analysts have also issued research reports about the stock. Weiss Ratings restated a "hold (c)" rating on shares of Nu Skin Enterprises in a report on Wednesday. Zacks Research upgraded shares of Nu Skin Enterprises to a "hold" rating in a research note on Tuesday, August 12th. Four equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $6.88.

Nu Skin Enterprises Trading Down 6.6%

NUS opened at $10.31 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. Nu Skin Enterprises has a fifty-two week low of $5.32 and a fifty-two week high of $14.62. The firm has a market capitalization of $510.32 million, a PE ratio of 5.13 and a beta of 0.97. The company's 50-day moving average is $11.44 and its 200 day moving average is $8.85.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.18. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The company had revenue of $386.14 million for the quarter, compared to analyst estimates of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, research analysts predict that Nu Skin Enterprises will post 1.05 earnings per share for the current fiscal year.

Insider Buying and Selling at Nu Skin Enterprises

In other news, Director Laura Nathanson sold 6,489 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $12.22, for a total transaction of $79,295.58. Following the completion of the transaction, the director directly owned 33,149 shares of the company's stock, valued at $405,080.78. This represents a 16.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Chayce David Clark sold 20,000 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total transaction of $239,400.00. Following the transaction, the executive vice president directly owned 233,140 shares of the company's stock, valued at $2,790,685.80. This represents a 7.90% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 58,926 shares of company stock worth $711,364. Insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Wedge Capital Management L L P NC bought a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at approximately $1,280,000. GAMMA Investing LLC grew its position in shares of Nu Skin Enterprises by 63.5% during the 3rd quarter. GAMMA Investing LLC now owns 3,036 shares of the company's stock valued at $37,000 after acquiring an additional 1,179 shares during the period. Tower Research Capital LLC TRC grew its position in shares of Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company's stock valued at $40,000 after acquiring an additional 2,614 shares during the period. Man Group plc grew its position in shares of Nu Skin Enterprises by 209.6% during the 2nd quarter. Man Group plc now owns 247,992 shares of the company's stock valued at $1,981,000 after acquiring an additional 167,902 shares during the period. Finally, BNP Paribas Financial Markets grew its position in shares of Nu Skin Enterprises by 2.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 348,646 shares of the company's stock valued at $2,786,000 after acquiring an additional 9,052 shares during the period. 82.84% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.